Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Pravin Kendrekar"'
Autor:
Svetlana G. Frolova, Ksenia M. Klimina, Ravinder Kumar, Aleksey A. Vatlin, Deepak B. Salunke, Pravin Kendrekar, Valery N. Danilenko, Dmitry A. Maslov
Publikováno v:
Antibiotics, Vol 10, Iss 1, p 6 (2020)
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a global burden, responsible for over 1 million deaths annually. The emergence and spread of drug-resistant M. tuberculosis strains (MDR-, XDR- and TDR-TB) is the main challenge in global TB
Externí odkaz:
https://doaj.org/article/eba55414ef7d4fe08d6edc68f9a37f3e
Autor:
Vinayak Adimule, Rangappa Keri, Shashanka Rajendrachari, Pravin Kendrekar, Chandrashekar V. Kulkarni
Publikováno v:
Journal of Materials Science: Materials in Electronics. 34
Publikováno v:
Benzimidazole
In the present investigation, novel amide derivatives of benzimidazole (4a-f) with different thiophene acids (a-f) coupled in the presence of 1-[Bis (dimethylamino) methylene]-1H-1, 2, 3-triazolo [4, 5-b] pyridinium 3-oxide hexafluorophosphate (HATU)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9c96db6b54161fb2cb68ff995935502
https://mts.intechopen.com/articles/show/title/synthesis-characterization-and-antimicrobial-properties-of-novel-benzimidazole-amide-derivatives-bea
https://mts.intechopen.com/articles/show/title/synthesis-characterization-and-antimicrobial-properties-of-novel-benzimidazole-amide-derivatives-bea
Publikováno v:
Topics in Catalysis.
Publikováno v:
Topics in Catalysis.
Publikováno v:
Topics in Catalysis.
Publikováno v:
Topics in Catalysis.
Autor:
Pravin Kendrekar
Drug Development for Malaria Provides readers with first-hand advice for the development of novel antimalarial drugs This book provides a systematic overview of antimalarial drug development and presents a wealth of data and insight from drug develop
Drug and Therapy Development for Triple Negative Breast Cancer The first comprehensive and up-to-date compilation of modern diagnostic and treatment methods for triple negative breast cancer In Drug and Therapy Development for Triple Negative Breast
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.